Inhibition of urokinase-type plasminogen activator (uPA) activity

Details for Australian Patent Application No. 2008316793 (hide)

Owner GENENTECH, INC.

Inventors Bazan, J. Fernando; Kirk, Peter

Agent Griffith Hack

Pub. Number AU-A-2008316793

PCT Pub. Number WO2009/055613

Priority 61/013,937 14.12.07 US; 61/000,625 26.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/055613 Priority application(s): WO2009/055613

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316794-Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction

2008316786-Interactive magnetic marker field for safety systems and complex proximity warning system